References
1. Li Q, Guan X, Wu P, et al. Early transmission dynamics in Wuhan,
China, of novel coronavirus–infected pneumonia. N Engl J Med.
2020;382(13):1199-1207.
2. Huang C, Wang Y, Li X, et al. Clinical features of patients infected
with 2019 novel coronavirus in Wuhan,China. Lancet. 2020;395:497-506.
3. Dong Y, Mo X, Hu Y, et al.
Epidemiological Characteristics of 2143 Pediatric Patients With 2019
Coronavirus Disease in China. Pediatrics.2020. pii:e20200702. doi:
10.1542/peds.2020-0702.
4. Lan L, Xu D, Ye G, et al. Positive RT-PCR Test Results in Patients
Recovered From COVID-19.JAMA 2020.doi: 10.1001/jama.2020.2783.
An J, Liao X,Xiao T, et al. Clinical characteristics of the recovered
COVID-19
patients with re-detectable positive RNA test.medRxiv
2020.03.26.20044222; doi:
https://doi.org/10.1101/2020.03.26.20044222.
The guidelines for diagnosis and treatment of 2019-nCoV infected
pneumonia
(the sixth edition draft) issued by the National Health Commission of
China In.
http://www.gov.cn/zhengce/zhengceku/2020-02/19/content_5480948.htm2020.
Xia W, Shao J, Guo Y, et al. Clinical and CT features in pediatric
patients with
COVID-19 infection: Different points from adults. Pediatr Pulmonol.
2020. doi: 10.1002/ppul.24718.
Gong L, Zhang CL, Zhen Q. Analysis of clinical value of CT in the
diagnosis of
pediatric pneumonia and mycoplasma pneumonia. Exp Ther Med.
2016;11(4):1271-1274.
Ling Y, Xu S-B, Lin Y-X, et al. Persistence and clearance of viral RNA
in 2019
novel coronavirus disease rehabilitation patients. Chin Med J (Engl)
2020. doi: 10.1097/CM9.0000000000000774.
Qu YM, Kang EM, Cong HY. Positive result of SARS-Co-2 in sputum from a
cured patient with COVID-19.Travel Medicine and Infectious Disease
2020:101619. doi: 10.1016/j.tmaid.2020.101619.
Xing Y-H, Ni W, Wu Q, et al.
Prolonged presence of SARS-CoV-2 in feces of
pediatric patients during the convalescent phase. medRxiv
2020.03.11.20033159; doi: https://doi.org/10.1101/2020.03.11.20033159.
Thompson LA, Rasmussen SA.What Does the Coronavirus Disease 2019
(COVID-19) Mean for Families?JAMA Pediatr. 2020.
doi:10.1001/jamapediatrics.2020.0828.
13. Channappanavar R, Perlman S. Pathogenic human coronavirus
infections: causes and consequences of cytokine storm and
immunopathology. Semin Immunopathol. 2017;39(5):529-539.
14. Chu H, Zhou J, Wong BH, et al. Middle East Respiratory Syndrome
Coronavirus Efficiently Infects Human Primary T Lymphocytes and
Activates the Extrinsic and Intrinsic Apoptosis Pathways. J Infect Dis.
2016;213(6):904-914.
Coleman CM, Sisk JM, Halasz G, et al. CD8+ T Cells and Macrophages
Regulate
Pathogenesis in a Mouse Model of Middle East Respiratory Syndrome. J
Virol. 2016;91(1). pii: e01825-16.
Gu J, Gong E, Zhang B, et al. Multiple organ infection and the
pathogenesis
of SARS. J Exp Med.2005;202(3):415-424.
Li T, Qiu Z, Zhang L, et al. Significant changes of peripheral T
lymphocyte
subsets in patients with severe acute respiratory syndrome. J Infect
Dis. 2004;189(4):648-651.
Wu C, Chen X, Cai Y, et al. Risk Factors Associated With Acute
Respiratory
Distress Syndrome and Death in Patients With Coronavirus Disease 2019
Pneumonia in Wuhan, China. JAMA Intern Med. 2020.doi:
10.1001/jamainternmed.2020.0994.
Antoniak S, Mackman N. Multiple roles of the coagulation protease
cascade
during virus infection.Blood. 2014;123(17):2605-2613.
Goeijenbier M, van Wissen M, van de Weg C, et al.Review: Viral
infections and
mechanisms of thrombosis and bleeding. J Med Virol.
2012;84(10):1680-1696.
Gralinski LE, Bankhead A 3rd, Jeng S, et al. Mechanisms of severe
acute
respiratory syndrome coronavirus-induced acute lung injury.mBio.
2013;4(4):e00271-e00313.
Tang N, Li D, Wang X, et al.
Abnormal coagulation parameters are associated
with poor prognosis in patients with novel coronavirus pneumonia. J
Thromb Haemost. 2020;18(4):844-847.